153 articles related to "India"
Visceral leishmaniasis (VL), also known as kala azar, is a worldwide protozoal vector-borne disease, endemic in 76 countries. The annual incidence is estimated to be 250-300,000 cases, with...
Briefing – Last updated 15 March 2013
DNP+, MSF urge India to reject EU demands before April deadline, protest at European Commission in Delhi New Delhi, 13 March 2013 – Pressure is mounting on India to quickly sign off on a free...
Press Release – Last updated 13 March 2013
New Delhi/Geneva, 4 March 2013 – The verdict into German pharmaceutical company Bayer’s appeal against the grant of a compulsory licence has been issued by India’s Intellectual Property...
Statements, Speeches, Letters – Last updated 04 March 2013
Generic competition saves lives. High medicine prices hurt patients and restrict the capacity of governments and other treatment providers to respond to medical needs. India’s contribution...
Briefing – Last updated 07 February 2013
Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug
Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 18 January 2013
HIV+ People and MSF Protest Outside Novartis Headquarters In Mumbai Ahead of Verdict in Novartis Vs. India Supreme Court Case
MUMBAI, 21 December 2012 -- As the Supreme Court considers its verdict in the case of Swiss pharmaceutical company Novartis vs. the Indian government, people living with HIV, Sankalp Rehabilitation...
Press Release – Last updated 26 December 2012
After 12 weeks of hearings in India's Supreme Court, Médecins Sans Frontières (MSF) has learnt that final arguments into the Novartis vs. Union of India case challenging the interpretation...
Web article – Last updated 04 December 2012
UPDATE ON THE CASE Hearings into the case commenced on 11 September 2012, with representatives for Novartis being the first to present their arguments. The court has also heard arguments from generic...
Web article – Last updated 16 November 2012
Multimedia – Last updated 25 September 2012
17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...
Statements, Speeches, Letters – Last updated 17 September 2012